X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.05
Delayed Data
As of Feb 13
 0.00 / 0.00%
Today’s Change
1.84
Today|||52-Week Range
4.70
-10.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses344.7K337.3K466.4K196.1K
 
 
 
 
 
Research And Development53.0K23.7K15.8K9.3K
 
 
 
 
 
Total Operating Expenses344.7K337.3K466.4K196.1K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-344.7K-337.3K-466.4K-196.1K
 
 
 
 
 
Extraordinary Charge-847.3K------
 
 
Other Expenses-12.0K-688.1K-1.0M1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-1.0M-1.5M1.6M
 
 
 
 
 
Net Income-1.2M-1.0M-1.5M1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M3.3M5.1M5.1M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M3.3M5.1M5.1M
 
 
 
 
 
 
Earnings Per ShareEPS---$0.31----
 
 
EPS Diluted-$0.40-$0.31-$0.32$0.31